The SLC7A7 gene helps move certain amino acids, including lysine, arginine, and ornithine, through the gut, kidneys, and some immune cells. If it does not work properly, the body may not absorb or keep enough of these building blocks, and protein rich meals can trigger nausea, vomiting, tiredness, or high ammonia levels in the blood. Pathogenic variants in the SLC7A7 gene cause lysinuric protein intolerance, a rare inherited condition that can also affect growth, the lungs, and the immune system.
What is a gene?
A gene is a stretch of DNA that carries instructions cells use to make molecules or regulate processes in the body. Some genes provide the directions for producing proteins, the parts of cells that do the work. Others mainly help control when certain processes happen, where they happen, and how strongly they occur. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. To explore this topic in more depth, you can read more in the LearnHub.
Overview
SLC7A7Gene function
What if the gene works
The SLC7A7 gene helps move certain amino acids, especially lysine, arginine, and ornithine, across cell membranes. This supports normal protein use and helps the intestines and kidneys keep amino acid levels balanced.
Risk
What if the gene does not work
Variants in the SLC7A7 gene can cause lysinuric protein intolerance, with protein-rich meals leading to nausea, vomiting, poor growth, and high blood ammonia. Effects range from milder to more severe and may also involve the lungs, kidneys, or immune system.
Treatment
What does that mean for your treatment
A pathogenic loss-of-function variant in the SLC7A7 gene points to treatment built around controlled protein intake, citrulline or sometimes arginine, and rapid treatment of high ammonia with nitrogen-scavenging medicines. Care is usually tailored over time, because lung, kidney, bone, or immune complications can affect which supportive medicines and monitoring are most helpful.
Conditions associated with SLC7A7
Gene function
What if the gene works
Your body needs steady movement of amino acids, the small building blocks used to make proteins. The SLC7A7 gene helps cells move a few key amino acids across the cell membrane so they can be reused and shared. Understanding SLC7A7 gene function helps explain how the body handles these nutrients during everyday digestion and kidney filtering.
The SLC7A7 gene helps move certain amino acids, especially lysine, arginine, and ornithine, across the cell membrane. This lets cells pass these nutrients from one side of the cell to the other in a controlled way.
Its protein works with a partner protein called SLC3A2 to form the transport system. Together they create a doorway that lets amino acids cross the membrane.
In the kidneys, this transport system helps return useful amino acids to the bloodstream after blood is filtered. That supports nutrient balance instead of letting these building blocks leave the body in urine.
In the small intestine, the same transport system helps move these amino acids from gut lining cells into the blood. This supports normal use of protein from food throughout the body.
What is a variant?
A genetic variant is a minor difference in the DNA sequence of a gene. These differences are common and help shape normal human diversity, including variations in appearance, metabolism, and how the body responds to environmental influences. Many variants do not cause any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many variants in the SLC7A7 gene change the y+LAT1 transporter so it is made incorrectly, breaks down early, fails to reach the cell surface, or moves lysine, arginine, and ornithine poorly. This explains how SLC7A7 gene variants affect amino acid transport at the cellular level. Some missense variants leave partial activity, while more disruptive splice, stop, or deletion variants often cause little or no function, which can be linked to earlier or more pronounced lysinuric protein intolerance.
How variants are linked to conditions
Pathogenic variants in the SLC7A7 gene cause lysinuric protein intolerance, a rare inherited condition that affects how the body handles certain amino acids from protein. People with this diagnosis may have vomiting after high protein meals, poor growth, tiredness, lung problems, or kidney involvement. Finding two pathogenic SLC7A7 variants can confirm the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common throughout the general population. Most do not have a direct effect on health and simply contribute to natural human variation. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors also play a role. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For SLC7A7, the main risk comes from inheritance: people usually develop the condition only if they are born with two changed copies of the gene, one from each parent. In those already living with it, high-protein meals and sometimes illness can make symptoms worse, while there is not enough evidence that lifestyle changes can prevent the condition itself.
Inheritance of SLC7A7 variants
Variants in the SLC7A7 gene are inherited in an autosomal recessive pattern. In practical terms, this means a child usually needs to inherit 2 changed copies of the SLC7A7 gene, 1 from each parent, to have SLC7A7-related lysinuric protein intolerance. Parents who each carry 1 changed copy are often unaffected, and with each pregnancy there is a 25% chance the child will inherit both changed copies, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither changed copy. This is the usual answer to how SLC7A7 gene variants are inherited in families.
What does my SLC7A7 result mean for my family?
For families with an SLC7A7-related condition, it is usually passed down in a recessive pattern, so parents are often healthy carriers and brothers or sisters may also be affected or be carriers. Close relatives may want to learn whether the same gene change runs in the family, especially if there is a history of poor growth, trouble handling protein-rich foods, or similar health problems. Children of someone with the condition are usually carriers unless the other parent also carries an SLC7A7 change.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the SLC7A7 gene, genetic testing for SLC7A7 variants uses DNA from a blood or saliva sample. A lab reads the gene’s code and sometimes checks for missing or extra pieces to identify changes that may help explain symptoms or confirm a diagnosis.
When should I consider getting a genetic test?
Genetic testing for the SLC7A7 gene may be worth considering if someone has signs of lysinuric protein intolerance, such as trouble handling protein-rich foods, poor growth, repeated vomiting, or high ammonia levels on blood tests. It can also help when this condition runs in the family or when a baby or child has unexplained symptoms that fit this pattern.
A genetic result is only one part of your health story
Genetic findings can be informative, but the amount they reveal depends on the specific condition and the kind of variant present. Over time, the way the body functions is shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, particularly those affected by many genes, genetic information provides context rather than certainty and makes the most sense when considered with other parts of care. In other situations, a genetic result can give a clear answer. For topics like medication response, genetic results may also help put a person’s experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in genes can change how a drug is absorbed, moved through the body, broken down, or sensed by its target. This helps explain why the same treatment works well for one person, seems weaker for another, or causes more side effects in someone else. These differences are common and are one part of the bigger picture, along with age, other health conditions, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that examines how differences in genes affect the way people respond to medications. It focuses on links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence both how the body processes a drug and how strong its effects are. This information can support treatment decisions that are more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the SLC7A7 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or adjusted. If you have questions about side effects, a new prescription, or how a treatment fits with your overall health, speak with your doctor or pharmacist.
History
Doctors first recognized the inherited condition now linked to the SLC7A7 gene through children who developed poor growth, stomach upset, and problems after eating protein. Many early reports came from Finland and Japan, where the condition was described more often than in many other countries. Initially understood only through visible traits, it was later recognized as tied to a specific gene when researchers identified the SLC7A7 gene in 1999. From these first observations, research expanded steadily, helping families receive a clearer genetic explanation for a condition that had once been defined only by symptoms and lab findings. This discovery also improved classification and made diagnosis more precise across different populations.